Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma.
Hashemi M, Mousavian Roshanzamir S, Orouei S, Daneii P, Raesi R, Zokaee H, Bikarannejad P, Salmani K, Khorrami R, Deldar Abad Paskeh M, Salimimoghadam S, Rashidi M, Hushmandi K, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: raesi r. Noncoding RNA Res. 2024 Feb 6;9(2):508-522. doi: 10.1016/j.ncrna.2024.02.002. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38511060 Free PMC article. Review.
EZH2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M, Nazdari N, Gholamiyan G, Paskeh MDA, Jafari AM, Nemati F, Khodaei E, Abyari G, Behdadfar N, Raei B, Raesi R, Nabavi N, Hu P, Rashidi M, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: raesi r. Pathol Res Pract. 2024 Jan;253:154988. doi: 10.1016/j.prp.2023.154988. Epub 2023 Nov 29. Pathol Res Pract. 2024. PMID: 38118215 Review.
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.
Hashemi M, Daneii P, Zandieh MA, Raesi R, Zahmatkesh N, Bayat M, Abuelrub A, Khazaei Koohpar Z, Aref AR, Zarrabi A, Rashidi M, Salimimoghadam S, Entezari M, Taheriazam A, Khorrami R. Hashemi M, et al. Among authors: raesi r. Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar. Noncoding RNA Res. 2023. PMID: 38075202 Free PMC article. Review.
Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer.
Hashemi M, Esbati N, Rashidi M, Gholami S, Raesi R, Bidoki SS, Goharrizi MASB, Motlagh YSM, Khorrami R, Tavakolpournegari A, Nabavi N, Zou R, Mohammadnahal L, Entezari M, Taheriazam A, Hushmandi K. Hashemi M, et al. Among authors: raesi r. Transl Oncol. 2024 Feb;40:101846. doi: 10.1016/j.tranon.2023.101846. Epub 2023 Dec 1. Transl Oncol. 2024. PMID: 38042134 Free PMC article. Review.
miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
Hashemi M, Khosroshahi EM, Chegini MK, Abedi M, Matinahmadi A, Hosnarody YSD, Rezaei M, Saghari Y, Fattah E, Abdi S, Entezari M, Nabavi N, Rashidi M, Raesi R, Taheriazam A. Hashemi M, et al. Among authors: raesi r. Pathol Res Pract. 2023 Nov;251:154906. doi: 10.1016/j.prp.2023.154906. Epub 2023 Oct 26. Pathol Res Pract. 2023. PMID: 37939448 Review.
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Bahonar A, Nakhaee Z, Entezari M, Beig Goharrizi MAS, Salimimoghadam S, Ren J, Nabavi N, Rashidi M, Dehkhoda F, Taheriazam A, Tan SC, Hushmandi K. Sadrkhanloo M, et al. Among authors: raesi r. Pathol Res Pract. 2023 Nov;251:154902. doi: 10.1016/j.prp.2023.154902. Epub 2023 Oct 21. Pathol Res Pract. 2023. PMID: 37922723 Review.
Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations.
Hashemi M, Gholami S, Raesi R, Sarhangi S, Mahmoodieh B, Koohpar ZK, Goharrizi MASB, Behroozaghdam M, Entezari M, Salimimoghadam S, Zha W, Rashidi M, Abdi S, Taheriazam A, Nabavi N. Hashemi M, et al. Among authors: raesi r. Cell Signal. 2023 Sep;109:110786. doi: 10.1016/j.cellsig.2023.110786. Epub 2023 Jun 27. Cell Signal. 2023. PMID: 37380085
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.
Hashemi M, Abbaszadeh S, Rashidi M, Amini N, Talebi Anaraki K, Motahhary M, Khalilipouya E, Harif Nashtifani A, Shafiei S, Ramezani Farani M, Nabavi N, Salimimoghadam S, Aref AR, Raesi R, Taheriazam A, Entezari M, Zha W. Hashemi M, et al. Among authors: raesi r. Environ Res. 2023 Sep 15;233:116458. doi: 10.1016/j.envres.2023.116458. Epub 2023 Jun 20. Environ Res. 2023. PMID: 37348629 Review.
18 results